Personal Information

First name Bagher

Surname Larijani

Birth date 1961

Office Address Endocrinology and Metabolism Research Center

Dr. Shariati Hospital, North Kargar Ave.

Tehran, 14114

Iran

Work Phone +98 (21) 802 6902-3

Email Address emrc@sina.tums.ac.ir

Education and TrainingsYear Degree Subject Organization

1987 MD Medicine Tehran University of Medical Sciences

1990 Specialty Internal Medicine Tehran University of Medical Sciences

1993 Post doctorate Endocrinology and Metabolism Tehran University of Medical Sciences

2000 Visiting faculty Saint Bartholomew Hospital London

2001 "Practical Diabetology" Course Steno Diabetes Center

2002 Medical Ethics London - UK

2002 WHO COHRED National Center for Medical Research-Tehran

2003 Osteoporosis course Lyon - France

2004 Endocrinology course Oxford - UK

2005 Islet Isolation Network Milan -Italy

Administrative Positions1. Chancellor Tehran University of Medical Sciences from October 20052. Vice Chancellor of Research , Tehran University of Medical Sciences (From 2001)3. Director of Endocrinology & Metabolism Ward of Dr. Shariati General Hospital (From

2001)4. Director of Endocrinology & Metabolism Research Center, Tehran University of

Medical Science (From 2001)5. Undersecretary for Culture, Ministry Of Health & Medical Education (Until 1995)6. Undersecretary for Student, Cultural & Legal, Ministry Of Health & Medical Education

(Until 1996)7. Undersecretary for Curative Affairs, Ministry Of Health & Medical Education (Until

1997)8. Secretary General of Charity Foundation of Special Diseases

1

9. Chief of Medicine and Health Department of the National Iranian Oil Corporation (NIOC)

10. Secretary of "Ethics in Research" Committee in Tehran University of Medical Sciences

11. Chief of Board of Directors of Medicine and Health Organization of Petroleum Industry

12. Director of Population Lab Researches in Tehran University of Medical Sciences13. Supervisor of Collaborations between Tehran University of Medical Sciences and

Iran University of Medical Sciences14. Specialist in Specialized Consultation Commissions of Medical Council of IRI15. Signing For the World Meeting On Medical Ethics with the World Community of

Ahlul-Bait16. Head of Medical Ethics research center

Editorial Positions1. Editor In Chief of Scientific Journal of Medical Council of IR of Iran2. Editor In Chief of the Special Disease Journal (Khas)3. Editor In Chief of Medicine and Purification Journal (Until 1997)4. Editorial Board of Iranian Journal of Public Health5. Editorial Board of Journal of Legal Medicine of IRI6. Editorial Board of Scientific Journal of Medical Council of IRI7. Board of Directors of the Iranian Society of Editors in Chief of Medical Journals8. Member of "Acceptance Policy and Networking of Medical Journals Workgroup" in Board

of Directors of the Iranian Society of Editors in Chief of Medical Journals9. Editorial Board of journal of Therapy10. Editorial Board of Journal of Advanced Research Yields in Atherosclerosis

Refereed Journal Articles1. Saudi Medical Journal2. Annals of Saudi Medicine3. Diabetes Care4. Indian Journal of Medical Sciences5. European Journal of Clinical Nutrition6. The Journal of Obstetrics and Gynecology Research

Memberships1. American Association Of Clinical Endocrinology (AACE)2. Professional Section Of The American Diabetes Association (ADA)3. International Osteoporosis Foundation (IOF)4. Thalassemia International Federation (TIF)5. International Diabetes Foundation(IDF)6. The Endocrine Society USA 7. European Association for cancer research(EACR)

2

8. Superior Council Of Islamic Medicine And Medical History Institute 9. Board Of Trustees Of Babul University Of Medical Science 10. Board Of Trustees Of Hamedan University Of Medical Science 11. Superior Council Of Medical Council Of Tehran 12. Superior Council Of Medical Council Of IRI13. Board Of Trustees Of Mazandaran University Of Medical Science14. Examining Board Of Endocrinology & Metabolism15. Medical Ethics Committee In Tehran University Of Medical Sciences16. Committee Of Recruiting Professors In Tehran University Of Medical Sciences17. Taskforce Of Guidance, Information, And Managing Curative Affairs In Tehran

University Of18. Medical Sciences19. Elected Committee For Upgrading The Faculty In Tehran University Of Medical

Sciences20. The Endocrine Society In Recognition Of Achievement In Clinical Practice, Research

And/Or Education In The Field Of Endocrinology21. The Reviewing Committee For Penalties Of Scientific Members Of Medical

Universities And Faculties In Iran22. The committee for development of ethics in medical researches

Honors and Prizes1. Kharazmi Festival Best Researcher 20042. Avicenna Festival, Best Medical Research Center, 20033. Rhazi Festival, Best Medical Research Center, 20034. Avicenna Festival, Best Books 2002 5. EMRC achievements, best fair, 20016. Assessment of clinical trial dissertations for medical ethics”, best dissertation, 19997. “Health in Islamic Republic of Iran”, edited book, 20008. “Diabetes and Pregnancy”, edited book, 20009. “A Comprehensive Look on Transplantation”, edited book, 200010. Illuminated Diploma of Honor” – International Biographical Center, Cambridge, England – June 2003, Cambridge University11. Eminent Scientist of the year 2005 ASIA-International Research Promotion Council.12. Rhazi Festival, Outstanding University of Medical Sciences on Research, Dec 2006

Journal Articles

Medicine & Purification1. Larijani B, Alavian M

Oral Hypoglycemic Agents, A review of literatureMedicine & Purification. 2(5):14-28, 1992 Fall

3

2. Malekzadeh R, Larijani B Trends in prevalence of diseases and concerns for diagnosis and treatment in geriatric Medicine in IRANMedicine & Purification. 6:1993 Winter

3. Larijani BA review of ethics in researchMedicine & Purification. 12:1994 Fall; 93-102

4. Larijani B, Bastanhagh MH Amenorrhea due to MitotanMedicine & Purification. 17:15-18, 1995

5. Larijani B, Bastanhagh MH, Pajouhi M, Nakhjavani M, Khajehdini HRetrospective study of thyroid cancer in hospitals of Tehran University of Medical Sciences, IRAN, 1983-1993Medicine & Purification. 19&20:12-17, 1995 Winter and Spring

6. Larijani BHirsutism: A review articleMedicine & Purification. 25:42-66, 1997

Journal of Tehran University of Medical Sciences, Faculty of Medicine

7. Larijani B, Retrospective study of craniopharyngioma in hospitals of Tehran University of Medical SciencesJournal of Tehran University of Medical Sciences, Faculty of Medicine. 1994

8. Larijani B, Bastanhagh MH, Pajouhi MRetrospective study of Nelson's syndrome in hospitals of Tehran University of Medical Sciences. 1985-1995Journal of Tehran University of Medical Sciences, Faculty of Medicine. 1:14-17, 1996

9. Larijani B, Bastanhagh MH, Pajouhi M, SarhadiStudy of pheochromocytoma in patients between 1989 and 1995Journal of Tehran University of Medical Sciences, Faculty of Medicine. 1997

10. Bastanhagh MH, Larijani B, Pajouhi M, Shariat MA Retrospective study of the prevalence of secondary diabetes following pheochromocytoma, Cushing's syndrome and acromegaly in Tehran University of Medical Sciences. 1979-1994Journal of Tehran University of Medical Sciences, Faculty of Medicine. 2&3, 1997

11. Larijani B, 93 cases of craniopharyngiomaJournal of Tehran University of Medical Sciences, Faculty of Medicine. 2002

4

Scientific Journal of Medical Council of IR of Iran12. Larijani B, Azizi F, Pajouhi M, Bastanhagh MH, Marsousi V, Hossein-Nezhad A,

Sadjadi SAGestational diabetes mellitus: a potential risk for pregnancyScientific Journal of Medical Council of IR of Iran. 16(2), 1998

13. Larijani B, Zahedi FDiabetic foot: prevention and managementScientific Journal of Medical Council of IR of Iran. 16(3):193-210, 1998

14. Larijani B, Rashidian AMedical Ethics in Clinical Trial Theses in Tehran University of Medical SciencesScientific Journal of Medical Council of IR of Iran. 17(1):65-73, 1999

15. Eshraghian MR, Larijani B, Nakhai F, Pajouhi M, Alimohammadian M, Sadjadi SAGestational diabetes mellitus risk factors and importance of them for Iranian pregnant womenScientific Journal of Medical Council of IR of Iran. 17(3):239-244, 1990

16. Larijani B, Bastanhagh MH, Pajouhi M, Talaei A, Sadjadi SA, Shirzad MEvaluation of nutrition state in new non insulin dependent diabetic patients and patients with glucose intolerance in Tehran 1995Scientific Journal of Medical Council of IR of Iran. 18(1):11-16, 2001

17. Sadr Sh, Larijani B, Pazouki HR, Sheikh-Hassani BComparison study of serum Zinc concentrations in patients with diabetes mellitus type 2 and controls using atomic absorption techniqueScientific Journal of Medical Council of IR of Iran. 18(2), 2001

18. Larijani B, Nakhjavani MAcromegaly, hypophysectomy, and diabetes type 2 incidences in previously normoglycemic patients. (Report of 5 cases)

Scientific Journal of Medical Council of IR of Iran. 18(3), 2001

19. Larijani B, Zahedi FIslamic fasting and diabetes: A review articleScientific Journal of Medical Council of IR of Iran. 18(4):313-322, 2001

20. Larijani B, Pajouhi M, Hossein-Gowhari L, Javadi E, Shafaei A, Mahmoudi MSerum fructose amine and diabetes control (a new model)Scientific Journal of Medical Council of IR of Iran. 19(1):21-27, 2002

21. Larijani B, Gharib-Doost F, Bastanhagh MH, Pajouhi M, Sadjadi SA, Eshraghian MREffects of suppressive therapy with Levothyroxin on bone mineral density in premenopausal womenScientific Journal of Medical Council of IR of Iran. 19(2):101-106, 2002

5

22. Larijani B, Fakhrzadeh H, Mohaghegh M, Pourebrahim R, Akhlaghi MREconomic costs of coronary artery diseases in National Iranian Oil Corporation in 1999Scientific Journal of Medical Council of IR of Iran. 19(4):287-292, 2002

23. Larijani B, Pajouhi M, Bastanhagh MH, Sadjadi SA, Eghbali F, Alimohammadian MPrevalence of abnormal thyroid function tests in elderly above 60 in elderly houses in TehranScientific Journal of Medical Council of IR of Iran. 20(4), 2003

24. Larijani B, Clinical and microscopic findings in craniopharyngiomaScientific Journal of Medical Council of IR of Iran. 22 (3), 175-178, 2004

25. Larijani B, Retrospective study of clinical and paraclinical findings of insulinomaScientific Journal of Medical Council of IR of Iran. 22 (2), 97-103, 2004

Iranian Journal of Endocrinology & Metabolism 26. Larijani B, Azizi F, Pajouhi M, Bastanhagh MH, Marsousi V, Hossein-Nezhad A,

Sadjadi SA.Prevalence of GDM in Iranian pregnant women referred to hospitals of the Tehran University of Medical Sciences (1993-1994)Iranian Journal of Endocrinology & Metabolism. 1(2):125-133, 1999

27. Pajouhi M, Larijani B, Bastanhagh MH, Abbasvandi F, Firouznia K, Shirzad M, Amini MR, Saraei M, Abbasvandi N, Baradar-Jalili R.Treatment of autonomous thyroid nodules by percutaneous ethanol injection: A two years follow upIranian Journal of Endocrinology & Metabolism. 1(3):173-178, 1999

28. Larijani B, Zahedi F.Hypoglycemia (part I)Iranian Journal of Endocrinology & Metabolism. 2(1):49-62, 2001

29. Larijani B, Zahedi F.Hypoglycemia (part II)Iranian Journal of Endocrinology & Metabolism. 2(2):121-136, 2001

30. Larijani B, Pajouhi M, Bastanhagh MH, Seddighi N, Sadjadi SA, Eshraghian MR, Baradar-Jalili R.Evaluation of suppressive therapy on cold thyroid nodules shrinkage with levothyroxin: a double blind placebo controlled clinical trialIranian Journal of Endocrinology & Metabolism. 3(1):1-9, 2001 Spring

31. Larijani B, Marsousi V, Moradi A, Hashemipour S.Thyroid hormone in preeclampsiaIranian Journal of Endocrinology & Metabolism. 3(2):101-107, 2001 Summer

32. Pajouhi M, Hosseini R, Larijani B, Bastanhagh MH, Soltani A, Baradar-Jalili R.

6

BMD in postmenopausal women with type 2 diabetes, compared with control groupIranian Journal of Endocrinology & Metabolism. 3(3):161-169, 2001 Fall

33. Khoshniat M, Larijani B, Ghavamzadeh A, Bahar B, Tabatabaei O.Effects of bone marrow transplantation on only regimen-growth chemotherapyIranian Journal of Endocrinology & Metabolism. 3(4):265-270, 2002 Winter

34. Larijani B, Azizi F, Bastanhagh MH, Pajouhi M, Hossein-Nezhad A.Prevalence of GDM in young womenIranian Journal of Endocrinology & Metabolism. 4(1):23-27, 2002 Spring

35. Khoshniat M, Larijani B, Ghavamzadeh A, Bahar B, Tabatabaei O.The function of thyroid, parathyroid, gonads, and beta cells of pancreas after BMT with chemotherapyIranian Journal of Endocrinology & Metabolism. 4(1):41-49, 2002 Spring

36. Yarahmadi Sh, Khosravi AR, Larijani B, Bayat M, Mahmoudi M, Baradar-Jalili RFungi flora and oral fungal infections in diabetic patientsIranian Journal of Endocrinology & Metabolism. 4(2):105-109, 2002 Summer

37. Larijani B, Retrospective study of pheochromocytoma in Tehran University of Medical Sciences 1989-1999Iranian Journal of Endocrinology & Metabolism. 5 (1); 33-37, 2003.

38. Larijani B, Therapeutic effects of epidermal growth factor on healing diabetic foot ulcerIranian Journal of Endocrinology & Metabolism. 5(2); 27-30, 2003

39. Larijani BThe effects of Ramadan Fasting on thyroid function test in healthy adults.Iranian Journal of Endocrinology & Metabolism. 5(2); 47-52, 2003

40. Larijani B, Dabbaghmaneh MH, Sedaghat M, Akrami SM, Hamidi Z, Rahimi R Defining cut of value in heel QUs and comparison with DXA for diagnosis of osteoporosis in Postmenopausal women.

Iranian Journal of Endocrinology & Metabolism. 6 (1); 39-45, 2004.

41. Haddadinezhad Sh, Larijani B, Tavangar SM, Nouraei SM.A comparison between fine needle aspiration and non-aspiration in evaluating thyroid nodules.

Iranian Journal of Endocrinology & Metabolism. 6 (2); 101-6, 2004.

Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

7

42. Bastanhagh MH, Larijani B, Sanjari M, Amini MR, Adibi H.The effects of Islamic fasting on fasting plasma glucose in healthy adults Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

43. Larijani B, Pajouhi M, Sanjari M, Shafaei A, Amini MR.The effects of Islamic fasting on lipid profiles in healthy adults Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

44. Shahrzad MK, Javadi E, Larijani B, Sanjari M, Baradar-Jalili R.The effects of Islamic fasting on thyroid function tests in healthy adults Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

45. Pajouhi M, Larijani B, Yarahmadi Sh, Sanjari M, Amini MR.The effects of Islamic fasting on sex hormones in healthy adult men Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

46. Yarahmadi Sh, Larijani B, Sanjari M, Javadi E, Baradar-Jalili R.The effects of Islamic fasting on sex hormones in healthy adult women Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

47. Larijani B, Bastanhagh MH, Sanjari M, Baradar-Jalili R, Hamidi Z.The effects of Islamic fasting on blood pressure, waist to hip ratio, body mass index, and physical activity in healthy adult women Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

48. Mohammadi MR, Larijani B, Sanjari M, Baradar-Jalili R.Anxiety and depression in Ramadan Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

49. Larijani B, Fakhrzadeh H, Sanjari M, Baradar-Jalili R, Amini MR.The effects of Islamic fasting on serum homocysteine levels Iranian Journal of Endocrinology & Metabolism (Special issue for "The congress on Islamic fasting and health", Fall 2001)

Nabz50. Jazayeri M, Bastanhagh MH, Larijani B, Esfahanian F, Lankarani M

Approach to Diabetic KetoacidosisNabz. 9, 1995

Journal of Special Diseases (Khas)51. Larijani B,

8

Diabetes and SportJournal of Special Diseases (Khas). 1(1):32-35, 1998

52. Larijani B, Shirazian N, Abbasvandi N, Baradar-Jalili RDiabetic KetoacidosisJournal of Special Diseases (Khas). 1(3), 1998

53. Larijani B, Endocrine disorders in thalassemiaJournal of Special Diseases (Khas). 1(4):74-81, 1999

54. Larijani B, Zahedi F.Secondary prevention of Diabetes Mellitus type 2Journal of Special Diseases (Khas). 2(6-7):91-96, 1999

The Journal of South Medicine55. Larijani B, Tabatabaei O.

Economic costs of diabetes careThe Journal of South Medicine. 4(2), 2002

56. Bastanhagh MH, Larijani B, Rahim-Tabrizi P, Khalilifard AR, Baradar-Jalili R.Evaluation of therapeutic effects of radioactive iodine on 700 patients with hyperthyroidism: A one to ten years follow upThe Journal of South Medicine. 4(2), 2002

57. Mahmoudi M, Kamkar M, Shamshirsaz A, Bekheirnia MR, Habibzadeh MR, Shamshirsaz AH, Larijani B.IGF-1 in Thalassemia and its association with bone mineral densityThe Journal of South Medicine. 5(1), 2002

58. Mahmoudi M, Shamshirsaz A, Bekheirnia MR, Kamkar M, Bouzari N, Pourzahed-Guilani N, Shamshirsaz AH, Larijani B.Bone mineral density and related serum markers in young patients with thalassemia.The Journal of South Medicine. 5(1), 2002

59. Larijani B, Soltani A, Pajouhi M, Bastanhagh MH, Mirfeizi Z, Dashti R, Hossein-Nezhad A.Biochemical parameters in different stages of vitamin D deficiency.The Journal of South Medicine. 5(1), 2002

60. Hashemipour S, Larijani B, Pajouhi M, Bastanhagh MH, Soltani A, Javadi E, Adibi H, Shafaei A, Baradar-Jalili R.Variations in bone mineral density in 20-69 years old residents in Tehran.The Journal of South Medicine. 5(1), 2002

61. Dabbah-Manesh MH, Larijani B, Pajouhi M, Soltani A, Akbari SM, Adibi H, Hamidi Z.Similarity between DEXA and QUS in detection of osteoporosis.The Journal of South Medicine. 5(1), 2002

9

62. Tabatabaei O, Shamshirsaz A, Bekheirnia MR, Kamkar M, Pourzahed-Guilani N, Bouzari N, Komeilian Z, Habibzadeh MR, Shamshirsaz AH, Larijani B.Endocrine and metabolic disorders in patients with thalassemia major: A multicenter study in east of Tehran.The Journal of South Medicine. 5(1), 2002

63. Soltani A, Larijani B, Sedaghat M, Adibi H, Hamidi Z, Shazandi H, Khalilifard AR, Hossein-Nezhad A .Risk factors for osteoporosis in postmenopausal women referring to the Bone Mineral Density unit in the Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences.The Journal of South Medicine. 5(1), 2002

64. Larijani B, Effects of chemotherapy on spermogram and male sex hormone in Hodgkin's disease and BMT candidates at Dr. Shariati Hospital.The Journal of South Medicine. In Press

Iranian Journal of Diabetes and Lipids (IJDL)65. Hossein-Nezhad A, Larijani B.

Economic costs of screening and diagnosis of gestational diabetes.IJDL. 1(1):31-40, 2001-2002 Fall and Winter

66. Larijani B, Zahedi F.Epidemiology of diabetes mellitus in Iran.IJDL. 1(1):49-55, 2001-2002 Fall and Winter

67. Yarahmadi Sh, Larijani B, Bastanhagh MH, Pajouhi M, Baradar-Jalili R, Zahedi F, Amini MR, Zendehdel K.Metabolic and clinical effect of Islamic fasting in patients with diabetes mellitus type 2.IJDL. 1(1):59-65, 2001-2002 Fall and Winter

68. Zahedi F, Larijani B.Coronary disease incidence risk in type 2 diabetes based on Framingham study.IJDL. 1(1):73-82, 2001-2002 Fall and Winter

69. Larijani B, Bastanhagh MH, Pajouhi M, Khani M, Shajarian M, Afshari M.Prevalence of amputation in diabetic feet.IJDL. 1(1):83-85, 2001-2002 Fall and Winter

70. Larijani B, Hossein-Nezhad A.Diabetes and pregnancy.IJDL. 1(2): 9-22, 2002 Spring and Summer

71. Larijani B.Primary prevention of diabetes mellitus type 2.IJDL. 1(2):87-106, 2002 Spring and Summer

10

72. Larijani B, Osfouri E.Prevalence of diabetes mellitus type 2 and glucose intolerance in 30-64 years population in Bushehr.IJDL. 1(2):119-122, 2002 Spring and Summer

73. Javadi E, Yarahmadi Sh, Larijani B, Mohammadi S, Shafaei A, Baradar-Jalili R.Prevalence of dyslipidemia in diabetic patients attending the diabetes clinic at Dr. Shariati University Hospital 1998-2000.IJDL. 1(2):133-137, 2002 Spring and Summer

74. Larijani B, Sanjari M, Zahedi F, Khalilifard AR, Amini MR, Rahimi E.Metabolic and clinical effects of Islamic fasting on fasting plasma glucose in healthy adults.IJDL. 1(2):149-152, 2002 Spring and Summer

75. Hossein-Nezhad A, Larijani B.Hypertensive disorders and gestational diabetes mellitus.IJDL. 1(2):159-164, 2002 Spring and Summer

76. Yarahmadi Sh, Larijani B, Javadi E, Nikdoust F, San'ati A.Relation between angina pectoris and hyperinsulinoma (insulinism).IJDL. 2(1), 2002-2003 Fall and Winter

77. Larijani B, Mosaffa N, Shoushtarizadeh P, Nouraei M, Javadi E, Shafaei A, Vassigh AR.

Evaluation of respiratory explosion in phagocytes (neutophiles and monocytes) in patients with diabetes type 2 using flmp and PMA activators.IJDL. 2(1), 2002-2003 Fall and Winter

78. Majdzadeh SR, Larijani BPopulation research center: application of research for community health promotionIJDL. 3, supplement 1, Spring and Summer 2004; 1-4

79. Fakhrazadeh H, Pour-Ebrahim R, Nouri M, Heshmat R, Javadi E, Rahimi I, Larijani BCardiovascular risk factors in an urban population (17th zone of tehran): tehran university population laboratory studyIJDL. 3, supplement 1, Spring and Summer 2004; 27-36

80. Larijani B, Mortaz Hejri S, Pour-Ebrahim R, Nouri M, Heshmat R,Shooshtarizadeh P, Bastanhagh MH

Evaluation of type 2 diabetes and impaired fasting glucose (ifg) among 25-64 aged inhabitants of tehran university of medical sciences population lab regionIJDL. 3, supplement 1, Spring and Summer 2004: 44-52

81. Fakhrzadeh H, Ebrahim pour P, Nouri M, Pourebrahim R, Heshmat R, Shoushtarizadeh P, Larijani B

Evaluation of prevalence of the metabolic syndrome in inhabitants of tehran university of medical sciences population labIJDL. 3, supplement 1, Spring and Summer 2004: 71-80

11

82. Jazayeri S, Nouri M, Pourebrahim R, Fakhrzadeh H, Larijani B.Food and nutrient intakes among 20-60 aged inhabitants of tehran university of medical sciences population lab regionIJDL. 3, supplement 1, Spring and Summer 2004: 81-89.

83. Fakhrzadeh H, Ghotbi S, Pour-Ebrahim R, Nouri M, Heshmat R, Shafaee A, Larijani B

Evaluation of total plasma homocysteine, folic acid and vitamin b12 in 25-64 aged inhabitants of tehran university of medical sciences population lab regionIJDL. 3, supplement 1, Spring and Summer 2004:99-110.

84. Mohammad Hossein Niknam, Ali Rafinejad, Ali Akbar Amirzargar, Farideh Khosravi, Bagher Larijani

Polymorphism in IFN gamma gene has a negative association with type 1 diabetes mellitus in iranian patientsIJDL.3,107-111, 2004.

85. Seyed Pejman Madani, Bagher Larijani, Mohammad Hashem Erfani, Ramin Heshmat

Comparison of clinical criteria with neurophysiologic findings of sural nerve in diagnosis of diabetic peripheral neuropathyIJDL.3, 135-140, 2004.

86. Hossein Fakhrzadeh , Anahita Hamidi , Rasoul Pourebrahim , Ramin Heshmat, Masoumeh Noori, Yalda Rezaeikhah , Bagher Larijani

Obesity and associated cardiovascular risk factors in iranian childrenIJDL.3, 175-183, 2004.

87. Negin Masoudi Alavi, Fazl allah Ghofranipour, Bagher Larijani, Fazl Allah Ahmadi, Asad Allah Rajab, Gholamhossein Babaei

Evaluation of effectiveness of community based interventions on controlling diabetes mellitus in tehran, 1382IJDL.3, 185-193., 2004.

88. Ali Mohammad Sharifi, Seyed Hadi Mousavi, Bagher LarijaniEffect of insulin on local and tissue ACE activity in diabetic ratsIJDL.3, 195-200., 2004.

89. Hasan Fallah Huseini, Bagher Larijani, Hossein Fakhrzadeh, Skahin Akhondzadeh, Bita Radjabipour, Taiebeh Toliat, Ramin Heshmat

The clinical trial of silybum marianum seed extract (silymarin) on type ii diabetic patients with hyperlipidemiaIJDL.3, 201-206., 2004

90. Hossein-Nezhad A, Maghbouli Zh, Larijani BThe incidence of diabetes and abnormal glucose tolerance in women at early postpartum with previous gestational diabetesIJDL.4, 27-34., 2004

91. Lankarani M, Bandarian F, Tabatabaei O, Pajouhi M, Larijani B

12

The effect of combination therapy with gliclazide and metformin in control of blood glucose of type 2 diabeticsIJDL.4, 59-63., 2004

92. Sharifi AM, Mousavi SH, Larijani BStudy of correlation between systolic blood pressure and angiotensin converting enzyme (ACE) activity in STZ induced diabetic rats. IJDL.4, 7-14, 2005

93. Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R, Larijani B Homocystein levels and its correlation to metabolic sundrome in 25-64 year old residents of the Tehranmedical university population labIJDL.4, 71-78, 2005

94. Lankarani M, Valizade N, Heshmat R, Shafaei AR, Amini MR, Nouri M, Aleyasin A.Evauation of dyslipidemia in polycystic ovary syndrome.IJDL.4, 79-87, 2005

95. Hamidi A, Bagheri A, Fakhrzadeh H, Heshmat R, Moayyeri A, Mahmoud MJ, Pourebrahim R, Tabatabaei O, Larijani B.

The relationship between leptin and insulin resistance in Iranian obese children.IJDL.4, 89-96, 2005

96. Larijani B, Zahedi F.Medicine and modern medical ethics.IJDL.4 supplementEthics in Clinical Research, 1-12, 2004.

97. Larijani B, Zahedi F, Malehafzali H. History and activities of medical ethics in Iran.

IJDL.4 supplementEthics in Clinical Research, 13- 24, 2004

98. Larijani B, Zahedi F. The impact of ethics philosophy on moral decision markings in medicine. IJDL.4 supplementEthics in Clinical Research, 25-38, 2004.

99. Larijani B, Motevaseli E. New methods of medical ethics education. IJDL.4 supplementEthics in Clinical Research, 39-46, 2004

100. Larijani B, Zahedi F, Asghari F.Ethics in genetic research.

IJDL.4 supplementEthics in Clinical Research, 71-82, 2004.

101. Larijani B, Zahedi F, Shidfar F.Ethics in tissue and organ transplantation researches.IJDL.4 supplementEthics in Clinical Research, 83-92, 2004

102. Larijani B, Zahedi F.

13

Ethical issues of cloning and stem cell research IJDL.4 supplementEthics in Clinical Research, 93-104, 2004

103. Larijani B, Ghaforifard S, Zahedi F. Ethical considerations in clinical education of medical students. IJDL.4 supplementEthics in Clinical Research, 105-109, 2004

104. Larijani B, Ghodsi MLeptin: Anew adipocyte hormone and its role in the obesity IJDL. 4 (3):1-10, 2005

105. Mohseni F, Hesam M, Dorkoosh F, Mahmoudy M, Rouini MR, Bastan HAgh MH, Larijani B, Rafee M.

Pharmacokinetic comparison between regular insulin and oral insulin based on superporous hydrogel polymers in healthy volunteers IJDL. 4 (3):19-26, 2005

106. Larijani B, Houshmand M, Dorraj GH, Darvishzadeh F.Prevalence of MT DNA mutation in type II diabetes mellitus.IJDL. 4 (3):35-47, 2005

107. Larijani B, Abolhasani F, Mohajeri Tehrani MR, Tabatabaei O. Prevalence of diabetes mellitus in Iran in 2000.IJDL. 4 (3):75-83, 2005

108. Zamani M, Tabatabaiefar MA, Savabi Esfahani A, Mostafavi F, Sotoudeh A, Larijani B.

Correlation between the cd4 gene polymorphism with type 1 diabetes mellitus in the iranian population.IJDL. 4 (4):1-10, 2005.

109. Maghbouli Z, Hossein-nezhad A, Larijani B.The predictive factors for postpartum diabetes mellitus after gestational diabetesIJDL. 4 (4):27-36, 2005.

110. Forouzandeh F, Aziz Ahari A, Abolhasani F, Larijani BEvaluation of foot neurovascular status in diabetic patients referred to diabetes clinic of dr. shariati hospital, 2003-2004IJDL. 4 (4):43-52, 2005

111. Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R, Noori M, Shafaei AR, LArijani B.

The relation of hyperhomocysteinemia with impaired glucose tolerance and diabetes (Tehran Homocysteine Survey).IJDL. 4 (4):65-72, 2005

112. Salari H, Farzami B, Pasalar P, Larijani B.Investigation of the number and affinity of insulin receptors in red blood cells of type 2 diabetics.

14

IJDL. 5(1):11-17, 2005

113. Yavari P, Siassi F, Jalali M, Mohammad K, Larijani B, Keshavarz A, Chamari M.The impact of b-group vitamins and antioxidants on serum levels of apolipoprotein a1 and b in type 2 diabetesIJDL. 5(1):25-34, 2005

114. Abolhasani F, Mohagerie Tehrani MR, Tabatabaei O, Larijani BBurden of diabetes and its complications in iran in year 2000IJDL. 5(1):35-48, 2005

115. Tabatabaei Malazy O, Heshmat R, Hejazy Mogaddam SA, Taheri E, Soheilykhah S, Darvishzadeh F, Larijani B

Comparison of two types of metformin (aria co. and merck co) in type 2 diabetic patients:double blind randomized clinical trialIJDL. 5(1):49-58, 2005

116. Fakhrzadeh H, Ghodsi M, Hamidi A, Moayyeri AR, Heshmat R, Poorebrahim R, Noori M, Larijani B.

Relation between leptin and bmi and hypertension in obese childrenIJDL. 5(1):75-82, 2005

117. Mohseni F, Hesam M, Dorkoosh FA, Mahmoudy M, Bastan Hagh MH, Rafiee Tehrani M , Larijani B.

The effect of oral insulin based on sph and sp on serum levels of glucose, insulin and c- peptide in healthy volunteers IJDL. 5(2): 89-98, 2005

118. Khayatian M, Farzami B, Mirzajani E, Larijani B, Taghikhani M, Bathaei SZ, Vardasbi S, Elmi-Akhouni E.

Effects of glucosamine on pancreatic glucokinase and hexokinase activities and their relationship to insulin secretion from isolated islets of normal and type 2 diabetic rats.IJDL. 5(2): 99-108, 2005

119. Fakhrzadeh H, Ghotbi S, Heshmat R, Pour-Ebrahim R, Nouri M, Shafaee A, Larijani B.

Determinants of total plasma homocysteine concentration in healthy Iranian adults: the Tehran homocysteine survey (2003-2004).IJDL. 5(2): 163-174, 2005

Adili F, Fakhrzadeh H, Nouri M, Makarem J, Larijani B.Knowledge, practice status and trends in risk factors for cardiovascular disease in inhabitants of Tehran University of Medical Sciences (population lab region).IJDL. 5(2): 175-1185, 2005

Journal of Iran University of Medical Sciences120. Tavangar SM, Sarvarian S, Larijani B, Nabbiuni M, Bandarian F.

15

Immunohistochemical study of pituitary adenomas comparing with clinical presentation in 102 paraffin blocked specimens.Journal of Iran University of Medical Sciences. 11(42):527-534, 2004.

121. Larijani B, Tabatabaei O, Soltani A, Taheri E, Pajouhi M, Bastanhagh MH, Mahmoudi M, Bandarian F, Mohammadzadeh N.

Comparison of the effect of desmopressin (DDAVP) tablet and intranasal spray on the treatment of central diabetes insipidus

Journal of Iran University of Medical Sciences. 11(40): 289-298, 2004

Pezeshky Emrooz122. Larijani B.

Prevalence of Gestational Diabetes.Pezeshky Emrooz. 1995 Summer

Journal of Medical Plants123. Ziaea SA, Larijani B, Fakhrzadeh H, Dastpak A, Bandarian F.

The effect of Psyllium in treatment of diabetes and hyperlipidemia in type 2 diabetic patientsJournal of Medical Plants. 3 (12), 41-50, 2004.

124. Fallah Hosseini H, Fakhrzadeh H, Larijani B, Sheikh Samani AH.Review of anti-diabetic medicinal plants used in traditional medicine.Journal of Medical Plants. 5 (suppl diabetes): 1-8

125. Fallah Hosseini H, Larijani B, Fakhrzadeh H, Heshmat R, Darvishzadeh F, Jafariazar Z, Sheikh Samani AH, Rahmani M.

The clinical investigation of Citrullus colocynthis schrad fruit in treatment of type 2 diabetic patients: a randomized double blind placebo controlled study.Journal of Medical Plants. 5 (suppl diabetes):31-35

126. Fallah Hosseini H, Zaree A, Heshmat R, Larijani B, Fakhrzadeh H, Rezaii Sharifabadi R, Naderi GA, Sheikh Samani AH.

The effect of of Citrullus colocynthis schrad fruit on oxidative stress parameters in type 2 diabetic patients.Journal of Medical Plants. 5 (suppl diabetes):55-58

Reproduction and Infertility

127. Haghighian Roodsary A, Tahbaz F, Arjmand B, Larijani B, Kimiagar M. Effect of Soy protein on bone markers in osteopenic menopause women.

Reproduction and Infertility. 6, 62-68, 2005

128. Larijani B, Mohajery Tehrani MR, Hamidi z, Soltani A. Osteoporosis prevention, diagnosis and treatment.

Reproduction and Infertility. 6, 5-25, 2005

16

129. Zolfaghari M, Taghizadeh Z, Maghbouli Zh, Keshtkar A A, Kazem nezhad A, Larijani B.

The incidence of osteoporotic hip fracture in 3 years follow-up of Iranian multicenters osteoporosis study.Reproduction and Infertility. 6, 37-42, 2005

130. Yousefinejad A, Larijani B, Majdzadeh SR, Madadi A, Zabihyean M, Parsapour AR, Tamini H, Soleimani H, ZAmani G, Nikbakht AR.

Designing and compiling a generic informed consent form for human volunteers participating in research. Reproduction and Infertility. 6 (5): 553-62, 2006

Iranian Journal of Public Health

131. Larijani B, Mohajery Tehrani MR, Hamidi z, Soltani A, Pajouhi M Osteoporosis global and Iranian aspects.

Iranian Journal of Public Health. Supplement Osteoporosis, 1-17, 2004

132. Moayyeri A, Soltani A, Larijani B, Abolhassani F Incidence of hip fractures among Iranian elderly population. Iranian Journal of Public Health. Supplement Osteoporosis, 29-33, 2004.

133. Keramat A, Larijani B, Adibi H, Chopra A, Hunjir VR, Patwardh B. Association between demographic factors and osteoporosis in urban Iranian post menopausal women. Iranian Journal of Public Health. Supplement Osteoporosis, 34-42, 2004

134. Haghighian Roodsary A, Maghbouli Zh, Tahbaz F, Larijani B, Kimiagar M. Role of Soy protein on bone turnover. Iranian Journal of Public Health. Supplement Osteoporosis, 43-48, 2004.

135. Ebrahimof S, Adibi H, Salehomom N, Hosseini S, Larijani B. Fruit and vegetables intake and bone mineral density in residents of villages surrounding Tehran Iranian Journal of Public Health. Supplement Osteoporosis, 49-56, 2004.

136. Pajouhi M, Maghbouli Zh, Mortaz Hejri S, Keshtkar AA, Saberi M, Larijani B. Bone mineral density in 10-75 year- old Iranian healthy women: Population base study. Iranian Journal of Public Health. Supplement Osteoporosis, 57-63, 2004.

137. Larijani B, Maghbouli Zh, Keshtkar AA, Soltani A, Ebrahimpour P, Mortaz Hejri S. Determining normal range of vitamin D based on PTH and bone mineral changes. Iranian Journal of Public Health. Supplement Osteoporosis, 64- 69, 2004

138. Mahdavi mazdeh M, Hamidi Z, Soltani A, Sedaghat M, Lessan Pezeshki M, Larijani B.

17

Bone mineral density in Iranian kidney graft recipients and its relation to biochemical and PTH serum levels. Iranian Journal of Public Health. Supplement Osteoporosis, 70-75, 2004

139. Larijani B, Soltani A, Keshtkar AA, Sedaghat M, Hamidi Z, Amiri-Moghaddam S. Relation Of reproductive factors and heel quantitative ultrasound parameters in normal women of Tehran.

Iranian Journal of Public Health. Supplement Osteoporosis, 76-81, 2004 140. Hamidi Z, Soltani A, Sedaghat M, Pajouhi M, Mortaz Hejri S, Larijani B.

Correlation between QUS of phalanx and DXA in assessment of bone structure of postmenopausal women.

Iranian Journal of Public Health. Supplement Osteoporosis, 82-85, 2004

141.Soltani A, Hafezi R, Keshtkar AA, Hamidi Z, Larijani B. How is the correlation between DXL and DXA in diagnosis of osteoporosis in post menopausal women? Iranian Journal of Public Health. Supplement Osteoporosis, 86-89, 2004.

142. Komeilian Z, Sdaghat M, Baradar Jalili R, Arzaghi S, Jaladat Y, LArijani B. Educational booklet effect on knowledge and practice of osteoporotic patients. Iranian Journal of Public Health. Supplement Osteoporosis, 90-95, 2004

143. B Larijani, M Shirzad, MA Mohagheghi,V Haghpanah,AR Moosavi Jarahi, SM Tavangar, AR Vassigh, A Hossein-nezhad, F Bandarian,R Baradar- Jalili

Epidemiologic Feature of Thyroid Cancer Based on Cancer Registry Data System.

Iranian Journal of Public Health. 34 (4),1-7, 2005

Journal of Qazvin Medical University144. Fakhrzadeh H, Larijani B, Bandarian F, Adibi H, Samavat T, Malek Afzali H, Javadi HR, Hojjatzadeh E.

The relationship between ischemic heart disease and coronary risk factors in population aged over 25 in Ghazvin: A population based study. The Journal of Ghazvin University of Medical Sciences. 9 (2): 26-34, 2005

Journal of Babol University of Medical Sciences145. Larijani B, Zahedi F, Parsapour M, Mohaghegh Dolatabadi M, Jafarian SM, Kazameini SM

A review of compiling and ratification of ethical guideline for organ and tissue transplantation Research in Iran. JBUMS. 8 (Suppl 3): 9-22, 2006

146. Feiz zadeh A, Asghari F, Keshtkar A, Fotohi A, Hamed Barghi G, Sobhani A, Homami S, Sadeghi S, AkhondzadehS, Yousefnejad A, Mohammadian M, Sadeghi H, Parsapour M, Saberi N, Aramesh K, Larijani B

Ethical guideline for clinical trials. JBUMS. 8 (Suppl 3): 23-32, 2006

18

147. Shidfar F, Kaviani A, Parsapour A, Haghighi Z, Aramesh A Vashaghani A, Keyhanidust Z, Mohammadian M, Larijani B.

Ethical guidelines of research on vulnerable groups. JBUMS. 8 (Suppl 3): 33-42, 2006

148. Ghafourifard S, Sadeghi S, Ramezanzadeh F, Aghahoseini, Alyasine, Shariat M, Hashemi H, Parsapour A, Aramesh K, Mohammadian M, Tara F, Rezaie M, Dibaie M, Kahbazi M, Hamami S, Larijani B.

A review of compiling of ethical guideline for gamete and fetus research in Iran JBUMS. 8 (Suppl 3): 43-48, 2006

149. Motevasseli E, Akrami M, Zeinali S, Modaresi MH, Parsapour A, Aramesh K, Mohammadian M, Larijani B.

A review of compiling of ethical guideline for genetic research in Iran JBUMS. 8 (Suppl 3): 49-54, 2006

150. Aledavoud SJ, Javadzadeh Bouri A, Sadeghi H, Sabzghabaie MAM, Latifi SM, Norouzian R, Larijani B.

Preparation of ethic codes for studies on laboratory animals. JBUMS. 8 (Suppl 3): 55-64, 2006

151. Larijani B, Zahedi F, Nouri M, Bagheri A, Malekafzali H. Ethics committees and international collaborative research in Iran and Japan (2002-2003)

JBUMS. 8 (Suppl 3): 65-76, 2006

152. Larijani B, Zahedi F, Nouri M, Bagheri A, Heshmat R, Motevasseli E, Golmakani MM, Taheri E, Komeilian Z, Malekafzali H.

Ethics committees and externally sponsored research in Iran. JBUMS. 8 (Suppl 3): 77-87, 2006

Archives of Dermatology153. Dowlati B, Firooz A, Larijani B, & et al.

Insulin quantification in patients with seborrheic dermatitis.Archives of Dermatology. 134, 1998 August

Endocrine Practice154. Larijani B, Pajouhi M, Bastanhagh MH, Sadjadi A, Sedighi N, Eshraghian MR.

Evaluation of suppressive therapy for cold thyroid nodules with levothyroxin: a double blind placebo controlled clinical trial.Endocrine Practice. 5(5):251-256, 1999

155. Larijani B.Efficacy of local epidermal growth factor in treatment of diabetic foot.Endocrine Practice. Supplement, 2001

156. Larijani B.Clinical features of gestational diabetes mellitus in Iranian pregnant women.

19

Endocrine Practice. Supplement, 2001

157. Larijani B.I131 therapy and hyperthyroidism: follow up of 700 patients.Endocrine Practice. Supplement, 2001

158. Larijani B.Clinical features of thyroid cancer in Iran.Endocrine Practice. Supplement, 2001

159. Larijani B.Assessment of oral fungal flora and prevalence of fungal infection in the mouth.Endocrine Practice. Supplement, 2001

160. Larijani B, Hossein-nezhad A, Rizvi SW, Munir S, Vassigh AR.Cost analysis of different screening strategies for gestational diabetes mellitus.Endocrine Practice. 9(6):504-9, Nov-Dec 2003

World Health Organization, Eastern Mediterranean Regional Offices (EMRO)

161. Mirsharifi SR, Alizadeh K, Ameli O, Larijani B.Prioritized list of health services in the Islamic Republic of Iran.World Health Organization, Eastern Mediterranean Regional Offices (EMRO). 6(2-3):357-371, 2000

Journal of Endocrinology162. Larijani B.

Coronary heart disease prediction in diabetic patients.Journal of Endocrinology. 164, 2000

163. Larijani B.Prevalence of gestational diabetes in 2100 women in Iran.Journal of Endocrinology. 164, 2000

164. Larijani B.Clinical features of 1318 cases with thyroid cancer in Tehran.Journal of Endocrinology. 164, 2000

165. Larijani B.Assessment of the micral test for early detection of microalbuminuria in patients with diabetic nephropathy.Journal of Endocrinology. 164, 2000

166. Larijani B.Effects of Islamic fasting on patients with diabetes type 2.Journal of Endocrinology. 164, 2000

20

167. Larijani B.Report of 35 cases of ethanol injection into autonomous thyroid nodule and two years follow up.Journal of Endocrinology. 164, 2000

Medical Journal of the Islamic Republic of Iran168. Mirzajani B, Farzami B, Sarrafnejad A, Larijani B, Myers M.

Monophasic state of insulin secretion in isolated rat islets of Langerhans by K+, Ca2+ and glucose.Medical Journal of the Islamic Republic of Iran. 14(3):289-292, 2000 November

Heart Journal169. Larijani B.

A cross sectional study of risk factor evaluation for coronary artery disease.Heart Journal. 2-4(1-3):48-53, 2001

Thermochemico ACTA170. Mohammadi-Nejad A, Mosavi-Movahedi AA, Safarian S, Naderimanesh MH, Ranjbar

B, Farzami B, Mostafavi H, Larijani B, Hakimelahi GH.The thermal analysis of nonenzymatic glycosylation of human serum albumin: differential scanning calorimetry and circular dichroism studies.Thermochemico ACTA. 389:1-11, 2002

Shiraz E Journal171. Larijani B.

Diabetes mellitus following hypophysectomy in previously normoglycemic patients with acromegaly (case report).Shiraz E Journal. 2002

172. Larijani B.Epidemiology of Diabetes Mellitus.Shiraz E Journal. 2002

Feiz Journal

173. Sanjari M, Larijani B, Baradar- Jalili R, Amini MR, Akrami SMThe effect of Ramadan fasting on insulin like growth factor 1 (IGF-1) and LDL in healthy adults.Feiz Journal. 35; 30-33, 2005

Proceedings of the International Congress on Molecular Diagnosis and Treatment of Thalassemia

174. Larijani B.Endocrine abnormalities in thalassemia.Proceedings of the International Congress on Molecular Diagnosis and Treatment of Thalassemia. Accepted 2003

21

Medical Journal of the Iranian Hospitals175. Larijani B.

1 to 10 years follow up of 700 hyperthyroid patients treated with I131.Medical Journal of the Iranian Hospitals. 5(2):9-14, 2002 June

176. Larijani B.Pheochromocytoma.Medical Journal of the Iranian Hospitals. 5(2):35-40, 2002 June

177. Larijani B.Effects of chemotherapy on spermogram and sex hormone levels in male BMT candidates with Hodgkin's disease and non-Hodgkin lymphoma at the Shariati Hospital, Tehran. 1999-2000.Medical Journal of the Iranian Hospitals. In Press

178. Ganji M R, Darvishzadeh F, Najafi I, Hakemi M, Larijani B.Prevention of type 2 diabetic nephropathy: a review of literature.Medical Journal of the Iranian Hospitals. 8 (2): 83-91

179. Larijani B, Afshari M, Darvishzadeh F, Bastanhagh MH, Pajouhi M, Jalili R, Moadi M.Lower limb amputation in patients with diabetes foot ulcer: A 22 year review.

Medical Journal of the Iranian Red Crescent. 8 (3): 21-24, 2006

Annals of Saudi Medicine180. Larijani B, Baradar-Jalili R, Sanjari M, Fakhrzadeh H, Amini MR.

Alterations in coronary heart disease risk profiles in healthy adults after Ramadan fasting.Annals of Saudi Medicine. 23(3):223-9, 2003

181. Larijani B, Aghakhani Sh, Moosavi Lor SS, Zahedi F, Pajouhi M, Bastanhagh MH.Insulinoma: Description and a 20-year review in academic centers in Iran Annals of Saudi Medicine. In press

ACTA Oncologica182. Larijani B.

Screening for microalbuminuria in the early detection of diabetic nephropathy.ACTA Oncologica. 40(2):65-68, 2002

183. Larijani B, Aghakhani S, Khajeh-dini H, Baradar-jalili R.Clinico-pathological features of thyroid cancer as observed in five referral hospitals in Iran: a review of 1177 cases. ACTA Oncologica. 42(4): 334-8, June 2003

Medical Journal of Malaysia184. Larijani B, Zahedi F, Sanjari M, Amini MR, Jalili RB, Adibi H, Vassigh AR.

The effect of Ramadan Fasting on fasting serum glucose in healthy adults.Medical Journal of Malaysia. 58(5):678-80, Dec 2003

22

Journal of Clinical Pharmacy and Therapeutics185. Larijani B, Gharibdoost M, Pajouhi A, Sadjadi A, Aghakhani S, Eshraghian R, Akrami

SM, Maalouf G.

Effects of levothyroxine suppressive therapy on bone mineral density in premenopausal women.

Journal of Clinical Pharmacy and therapeutics. 29(1):1-5, Feb 2004

Biological Trace Element Research186. Bekheirnia MR, Abdollah Shamshirsaz A, Kamgar M, Bouzari N, Erfanzadeh G,

Pourzahedgilani N, Tataie SM, Abllah Shahirsaz A, Kimiagar M, Ezzati F, Larijani B.

Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents.

Biological Trace Element Research. 97(3):215-24, Mar 2004

Endocrine Pathology187. Shirzad M, Hedayat A, Kamalian N, Larijani B, Baradar-Jalili R.

Diagnostic value of frozen section examination (F5) in thyroid nodule surgery in patients referring to Dr. Shariati hospital, 1997-2000.Endocrine Pathology. 14(3):1-6, 2003

188. Haddadi-Nezhad Sh, Larijani B, Tavangar SM, Nouraei SMComparison of fine-needle-nonaspiration with fine-needle-aspiration technique in the cytologic studies of thyroid nodules. Endocrine Pathology. 14(4):369-73, Winter 2003

189. Tavangar SM, Larijani B, Mahta A, Abdolahzadeh Hosseini SM, Mehrazine M, Bandarian F.

Craniopharyngioma: A clinicopathological study of 141 cases. Endocrine Pathology. 15(4), 339-344, 2004.

Journal of College of Physicians and Surgeons Pakistan (JCPSP)

190. Yarahmadi Sh, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F, Zendehdel K, Akrami SM.Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. JCPSP. 13(6):329-32, June 2003

191. Larijani B, Nakhjavani M, Baradar-Jalili R, Akrami SM, Bandarian F.Diabetes mellitus following pituitary adenomectomy in euglycemic patients with acromegaly.JCPSP. 15 (7): 430-432, 2005

Proceedings of 15th European congress of Clinical Chemistry & Laboratory Medicine

23

192. Javadi E, Kazerouni, Dousti, Larijani B.LDL subclass patterns and atherogenecity in non-insulin dependent diabetes mellitus. p.495-499, 2003

Gynecological Endocrinology193. Larijani B, Marsoosi V, Aghakhani S, Moradi A, Hashemipour S.

Thyroid hormone alternation in pre-eclamptic Women.Gynecol Endocrinol. 18(2):97-100, Feb 2004

194. Sabour H, Hossein-Nezhad A, Maghbooli Z, Madani F, Mir E, Larijani B. Relationship between pregnancy outcomes and maternal vitamin D and calcium intake: A cross-sectional study.Gynecol Endocrinol. 22(10):585-9, 2006

Transplantation Proceedings195. Ghavamzadeh A, Larijani B, Jahani M, Khoshniat M, Bahar B, Tabatabaei O.

Thyroid, parathyroid, gonadal, and pancreatic beta-cell function after bone marrow transplantation with chemotherapy-only conditioning.Transplantation Proceedings. 35(8):3101-4, Dec 2003

196. Khoshniat M, Ghavamzadeh A, Larijani B, Bahar B, Tabatabaei O.Effect on growth parameters of bone marrow transplantation with a chemotherapy-only conditioning regimen. Transplantation Proceedings. 35(8):3085-8, Dec 2003

197. Zahedi F, Larijani B.Ethical and legal aspect of organ transplantation in Iran. Transplantation Proceedings. 36 (5), 1241-1244, 2004

198. Larijani B, Zahedi F, Ghafouri-Fard S. Rewarded gift for living renal donors. Transplantation Proceedings.36 (9), 2539-2542, 2004

199. Larijani B, Zahedi F. Islamic perspective on human cloning and stem cell research. Transplantation Proceedings.36 (10): 3188-9, 2004.

200.Pajouhi M, Mahdavi-Mazdeh M, Larijani B, Soltani A, Sedaghat M, Hamidi Z. Assessment of Bone Structure in Renal Transplant Recipients: Comparison of Phalangeal Qualitative Ultrasound and Dual X-Ray Absorptiometry. Transplantation Proceedings. 37 (7):3112-3115, 2005.

201.Amoli MM, Mousavizadeh R, Sorouri R, Rahmani M, Larijani B. Curcumin Inhibits in Vitro MCP-1 Release From Mouse Pancreatic Islets.Transplantation Proceedings. 38(9):3035-8, 2006.

24

European Journal of Cancer Care (English)202. Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F, Vassigh A, Aghakhani S.

Presentation and outcome of 93 cases of craniopharyngioma.European Journal of Cancer Care. 13(1):11-5, Mar 2004

Progress in Neuopsychopharmacology and Biologic Psychiatry

203. Akhondzadeh S, Nejatisafa AA, Amini H, Mohammadi MR, Larijani B, Kashani L, Raisi F, Kamalipour A.Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.Progress in Neuo-Psychopharmacology and Biologic Psychiatry. 27(6):1007-12, Sep 2003

BMC Endocrine Disorders204. Abdollah Shamshirsaz A, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N,

Habibzadeh M, Hashemi R, Abdollah Shamshirsaz AH, Aghakhani S, Homayoun H, Larijani B.Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.BMC Endocrine Disorders. 3(1):4, Aug 2003

205. Larijani B, Pajouhi M, Ghanaati H, Bastanhagh MH, Abbasvandi F, Firooznia K, Shirzad M, Amini MR, Sarai M, Abbasvandi N, Baradar-Jalili R.Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection.BMC Endocrine Disorders. 2(1):3, Dec 2002

206. Alavian SM, Hajarizadeh B, Nematizadeh F, Larijani B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver Disease.

BMC Endocrine Disorders. 4, 4, 2004.

207. Moayyeri A, Soltani A, Tabari NK, Sadatsafavi M, Hossein-Neghad A, Larijani B. Discordance in diagnosis of osteoporosis using spine and hip bone densitometry. BMC Endocr Disord. 11;5(1):3, 2005

American Journal of Human Biology208. Larijani B, Bekheirnia MR, Soltani A, Khalilifard A, Adibi H, Baradar-Jalili R.

Bone Mineral Density is related to Blood Pressure in Men.American Journal of Human Biology. 16(2):168-71, Mar-April 2004

Asian Pacific Journal of Cancer Prevention209. Larijani B, Shirzad M, Mohagheghi MA, Haghpanah V, Mosavi-Jarrahi AR, Tavangar

SM, Vassigh AR, Hossein-Nezhad A, Bandarian F, Baradar-Jalili R. Epidemiologic analysis of the Tehran Cancer Institute Data System Registry (TCIDSR).Asian Pacific Journal of Cancer Prevention. 5(1):36-9, Jan-Mar 2004

25

Pharmacological Research210. Sharifi AM, Mousavi SH, Larijani B.

Study of interaction between nitric oxide and ACE activity in STZ-induced diabetic rats: role of insulin. Pharmacological Research. 50(3):261-6, Sep 2004

Vascular Pharmacology211. Sharifi AM, Akbarloo N, Darabi R, Larijani B.

Study of correlation between elevation of blood pressure and tissue ACE activity during development of hypertension in 1K1C rats. Vascular Pharmacology. 41(1):15-20, Feb 2004

Eastern Mediterranean Health Journal (EMHJ)212. Larijani B, Fakhrzadeh H, Mohagheghi MA, Pourebrahim R, Akhlaghi MR, Rahimi E

Economic costs of coronary heart diseases in the National Iranian Oil Corporation (NIOC) in 1999-2000. EMJH. accepted

213. Larijani B, Zahedi F, Malek-Afzali H. Medical ethics in the Islamic Republic of Iran. East Mediterr Health J. 11(5-6):1061-72, 2005.

214. Fakhrzadeh H, Bandarian F, Adibi H, Malekafzali H, Samavat T, Larijani B.Coronary heart diseases and associated risk factors in IQazvin, iran: A population based study.EMJH. Accepted

215. Omrani GH, Larijani B, et al.Effect of menopause and renal function on vitamin D status in Iranian women

East Mediterr Health J. 12 (1/2):188-195, 2006.

Toxicology Letters216. Sharifi AM, Akbarloo N, Darabi R, Larijani B, Khoshbaten.

Investigation of circulatory and tissue ACE activity during development of lead induced hypertension. Toxicology Letters. 153 (2); 233-8, 2004.

Evidence-Based Mental Health217. Soltani A, Moayyeri, Raza M, Larijani B.

Impediments to implementing evidence-based mental health in developing countries. EBMH. 1009 Topics: 189;190;200;161;21

Archives of Iranian Medicine218. Larijani B, Hossein-Nezhad A, Vassigh AR.

26

Effect of Varying Threshold and Selective Versus Universal Screening on the cost of screening Strategis for gestational diabetes mellitus.

Archives of Iranian Medicine. Vol 7 (4): 267-271, 2004.

International Journal of Pharmacology219. Larijani B, Hashemipour S, baradar- Jalili R, Mohajeri MR, Sadjadi SA.

The Effect of Sandostatin LAR in the Treatment of AcromegalyInternational Journal of Pharmacology. 2005, 1(4): 342-5.

220. MH Bastan-hagh, B. Larijani, P. Rahim-Tabrizi, AR. Khalili-Fard, R.Baradar-Jalili. Treatment of 1035 hyperthyroid patients with 131-iodine

Int J Pharmacology. 2 (1): 116-120, 2006

  Endocrinological Investigation

221. Moayyeri A, Larijani B.Artificial neural networks in prediction of bone density among post menopausal women

Endocrinological Investigation. 2005, 28(5), 425-31.

Biomedicine & Pharmacotherapy

222. Afshari M, Larijani B, Rezaie A, Mojtahedi AR, Zamani MJ, Astanehi-Asghari F, Mostafalou S, Hossein-nezhad A, Heshmat R, Abdollahi M

Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial.Biomedicine & Pharmacotherapy. 58 (10), 546-550, 2004.

223. Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi MEffects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial

Biomed Pharmacother. 59: 302-306, 2005

224. Roja Rahimi a, Shekoufeh Nikfar a, Bagher Larijani, Mohammad Abdollahi A review on the role of antioxidants in the management of diabetes and its complications Biomed Pharmacother. 59 (7): 365-73, 2005

German Journal of Psychiatry

225. Larijani B, Khoram Shahi Baiat M, Khalili Gorgani M, Bandarian F, Akhondzadeh Sh, Sadjadi SA.

Association between depression & diabetes. German Journal of Psychiatry. 7, 62-65, 2004.

BMC Public Health

27

226. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, Soltani A, Shafaei AR, Hamidi H, Khalili Fard AR, Hossein-Nezhad A, Booya F.

Vitamin D deficiency and causative factors in the population of Tehran.BMC Public Health. 4 (1), 38, 2004.

227. Fakhrzadeh H, Ghotbi S, Pourebrahim R, Nouri M, Heshmat R, Bandarian F, Shafaee AR, Larijani B

Total plasma homocysteine folic acid and vitamin B12 status in healthy Iranian adults the Tehran homocysteine survey (2003-4)BMC Public Health. 6(1): 29, 2006.

Indian Journal of Medical Sciences

228. Nabipour I, Imami SR, Mohammadi MM, Heidari G, Bahramian F, Azizi F, Khosravizadegan Z, Pazoki R, Soltanian AR, Ramazanzadeh M, Emadi A, Arab J, Larijani B.

A school-based intervention to teach 3-4 grades children about healthy heart; The persian gulf healthy heart project.Indian Journal of Medical Sciences. 58(7):289-96, 2004.

Ultrasound in Medicine229. Larijani B, Dabbaghmanesh MH, Aghakhani S, SedaghatM, Hamidi Z, Rahimi E

Defining cut-off values for identifying osteoporosis in postmenopausal women by quantitative heel ultrasonography. Ultrasound in Medicine. 2005, 24(7): 941-6

Osteoporosis International

230. Kamgar M, Shamshirsaz AA, Bekheirnia MR, et al.Insulin-like growth factor-I in thalassemic patients and its relationship to bone mineral density and puberty Osteoporosis international 15: S14-S14 Suppl. 2 NOV 2004 231. Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al.Bone mineral density and selected metabolic markers in thalassemia: A case-control study Osteoporosis international 15: S14-S14 Suppl. 2 NOV 2004

232. Moayyeri A, Soltani A, Larijani B, et al.Effects of hypovitaminosis D on peak bone mass of Iranian young men Osteoporosis international 15: S30-S30 Suppl. 2 NOV 2004

233. Bekheirnia MR, Soltani A, Hossein-nejad A, et al.Central obesity is associated with bone mass: A survey on men and women Osteoporosis international 15: S44-S45 Suppl. 2 NOV 2004

234. Moayyeri A, Soltani A, Larijani B, et al.Relations between estimation of height reduction and bone mineral density among Iranian population Osteoporosis international 15: S47-S47 Suppl. 2 NOV 2004

28

235. Sadatsafavi M, Moayyeri A, Soltani A, et al.Artificial neural networks in prediction of bone density among post-menopausal women Osteoporosis international 15: S48-S48 Suppl. 2 NOV 2004

236. Sadatsafavi M, Moayyeri A, Soltani A, et al.Evaluation of screening tools for selection of post menopausal women for bone densitometry in an Iranian population Osteoporosis international 15: S48-S48 Suppl. 2 NOV 2004 237. Bekheirnia MR, Shamshirsaz AA, Kamgar M, et al.Low bone mass and its relation to serum zinc and copper in young beta-thalassemic patients Osteoporosis international 14: S20-S20 Suppl. 7 2003

238. Larijani B, Pajouhi M, Komeylian Z, et al.Efficacy of educational pamphlets for improvement of knowledge and practice in patients with osteoporosis referred to osteoporosis clinic of endocrinology and metabolism research center

Osteoporosis international 14: S40-S41 Suppl. 7 2003

239. Soltani A, Hossein-Nezhad A, Larijani B, et al.Bone mineral density and its biochemical parameters measurements in Iranian healthy men Osteoporosis internationaL 14: S45-S45 Suppl. 7 2003

240. Larijani B, Javadi E, Hossein-Nezhad A, et al.Correlation between bone mineral density with calcium and vitamin D intake and there plasma concentration Osteoporosis international 14: S45-S46 Suppl. 7 2003 241. Hossein-Nezhad A, Larijani B, Soltani A, et al.Type 2 diabetes mellitus and the effects of lifestyle on bone mineral density in pre-and postmenopausal women Osteoporosis international 14: S46-S46 Suppl. 7 2003

242. Pajouhi M, Sedaghat M, Larijani B, et al.Relation of reproductive factors and heel QUS parameters in normal women of Tehran (20-70 Y/O) Osteoporosis international 14: S51-S51 Suppl. 7 2003

243. Moayyeri A, Ahmadi-Abhari S, Hossein-Nezhad A, Larijani B, Soltani A. Bone mineral density and estimated height loss based on patients' recalls.Osteoporosis international. 2006 Mar 31.

244. Moayyeri A, Ahmadi-Abhari S, Hossein-Nezhad A, Larijani B, Soltani A. Bone mineral density and estimated height loss based on patients' recalls. Osteoporos Int. 2006 Mar 31

245. Moayyeri A, Soltani A, Larijani B, Naghavi M, Alaeddini F, Abolhassani F. Epidemiology of hip fracture in Iran: results from the Iranian Multicenter Study on Accidental Injuries.Osteoporos Int. 2006 May 6; [Epub ahead of print]

Diabetologia

29

246. Larijani B, Hossein-Nezhad A, Bastanhagh MH, et al.Prevalence and risk factors for postpartum carbohydrate intolerance in women with gestational diabetes mellitus. Diabetologia 46: 724 Suppl. 2 AUG 2003

Toxicology and Applied Pharmacology

247. Azizi E , Larijani B, Moradian K, Fouladdel S. Anti proliferative effects of tamoxifen in the presence of high glucose concentrations on T47D and TAMR-6 cells Toxicology and Applied Pharmacology. 197 (3): 286-287 607 JUN 15 2004

Disease Markers

248. Amoli MM, Larijani B, Thomson W, Ollier WE, Gonzalez-Gay MA. Two polymorphisms in the epithelial cell-derived neutrophil-activating peptide (ENA-78) gene.Dis Markers; 21(2):75-7, 2005

Archives of Medical Research249. Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, Abdollahi M.

Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients.Arch Med Res. 2005;36(4):376-81.

Human Embryonic Stem Cells Research250. Larijani B, Zahedi F, Malek- afzali H.Current bioethical activities in Iran. Country Report.Iran.

Human Embryonic Stem Cells Research. 22 Sep 2003, pp: 360. Japan

Journal Human Hypertension251. Hossein Fakhrzadeh, Sara Ghotbi, Rasoul Pourebrahim, Ramin Heshmat, Masoumeh Nouri , Alireza Shafaee , Bagher Larijani Plasma Homocysteine Concentration and Blood Pressure in Healthy Iranian Adults: the Tehran Homocysteine Survey (2003-2004)

J Human Hypertension. 19(11): 869-76, 2005

Development Bioethics252. Bagher Larijani, Hossein Malek-afzali, Farzaneh Zahedi.

Strengthening medical ethics by strategic plan in Islamic republic of Iran.

Developing World Bioethics. 6 (2): 106-110 : 2006

Therapy

253. M. Afshari, B. Larijani, M. Fadayee, F. DARVISHZADEH, A. Ghahary, M. Pajouhi, MH Bastanhagh, R. Baradar-Jalili, AR Vassigh.

30

Efficacy of Topical Epidermal Growth Factor in Healing Diabetic Foot Ulcers

Therapy. 2 (5): 759-65, 2005

254. Larijani B. Akhondzadeh SIs there a relationship between estrogen serum level and symptom severity throughout the menstrual cycle of patients with schizophrenia?

Therapy. 2 (5): 745-51, 2005

255. Khalegh Nejad N, Larijani B.Report of the International Conference on Diabetes and Obesity

Therapy2 (5): 693-97, 2005

256. Abdollahi M, Larijani B.Role of oxidative stress in osteoporosis

Therapy. 2 (5): 787-96, 2005

257. Larijani B, Pajouhi M, Bastanhagh MH, Sadjadi A, Aghakhani S, Zare F , Sedighi N, Eshraghian MR, Nadjafi AH, Amini MR, Adibi H , Akrami SM

Levothyroxine Suppression Therapy on Solitary Thyroid Nodules (Follow-up 2 years).Therapy. 2 (6): 883-8, 2005

258. Larijani B, Afshari M, Astanehi-Asghari F, Mojtahedi A, Rezaie A, Hosseinnezhad A, Heshmat R, Mohammadirad A, Abdollahi M

Effect of short term carvedilol therapy on salivary and plasma oxidative stress parameters and plasma glucose level in type II diabetes.

Therapy. 3 (1): 883-8, 2006

BMC Musculoskeletal Disorders259. Larijani B, Hossein-Nezhad A, Mojtahedi A, Pajouhi M, Bastanhagh MH, Soltani A, Mirfezi SZ, Dashti R

Normative data of bone Mineral Density in healthy population of Tehran, Iran: A Cross sectional study.

BMC Musculoskeletal Disorders. 6: 38, 2005

Medical Principles and Practice260. B. Larijani, M.A. Mohagheghi, M.H. Bastanhagh, A.R. Mosavi-Jarrahi, V. Haghpanah, S.M. Tavangar, F. Bandarian, N. Khaleghian

Primary malignancies of thyroid in Tehran, Iran.

Medical Principles and Practice. 14(6):396-400, 2005

Journal of Ethnophamacology261. S.A. Ziai, B. Larijani, Sh. Akhoondzadeh, H. Fakhrzadeh, A. Dastpak, F. Bandarian, A. Rezai, H. Naghdi Badi, T Emami

Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients.

Journal of Ethnophamacology. 102: 202-7, 2005

31

Acta Neurologica Scandinavica262. Larijani B, Frouzandeh F, Ahari AR, Abolhasani F.

Comparison of different screening tests for detecting the diabetic foot neuropathy.Acta Neurologica Scandinavica. 112(6):409-13, 2005

Pediatrics International

263. Fakhrzadeh H, HAmidi A, Moayyeri AR, Larijani BObesity and associated cardiovascular risk factors in Iranian children: A cross sectional study.

Pediatrics International. 2005 in press.

Austral-Asian J Cancer264. Larijani B, Aghakhani S, Haghpanah V, Mosavi-Jarrahi AR, Bastanhagh MH

Review of thyroid cancer in Iran.Austral-Asian J Cancer. 2005 in press

Metabolic Syndrome and Related Disorders

265. Fakhrzadeh H, Ebrahim Pour P, Pourebrahim R, Heshmat R, Noori M, Larijani BMetabolic cardiovascular syndrome: A study of underlying factors in Iran.Metabolic Syndrome and Related Disorders. 4 (1): 28-34, 2006.

266. Fakhrzadeh H, Ebrahim Pour P, Larijani B Metabolic syndrome and related insulin levels in Iranian obese children.

Metabolic Syndrome and Related Disorders. In press.

Daru 267. Larijani B, Tabatabaei O, Soltani A, Taheri E, Pajouhi M, Bastanhagh MH, Akhondzadeh S, Mahmodi M, Bandarian F, Mohammadzade N

Comparison of Desmopressin (DDAVP) Tablet and Intranasal Spray in the Treatment of Central Diabetes Insipidus.

Daru. 13 (4): 155-9, 2005.

268. Larijani B, Zahedi F, Nouri M, Bagheri AR, Heshmat R, Motevasseli E, Golmakani M, Taheri E, Komeilian Z, Malekafzali H.

Ethics committee and externally sponsored research in Iran

Daru. Suppl 1;1-6, 2006.

269. Larijani B, Zahedi F.Health promotion Islamic ethics and law in Iran Daru. Suppl 1;7-9, 2006.

32

270. Larijani B, Zahedi F. An introductory on medical ethics history in different era in Iran

Daru. Suppl 1;10-16, 2006.

271. Larijani B, Motevasseli E.Needs and necessities of medical ethics education

Daru. Suppl 1;21-27, 2006.

272. Zahedi F, Larijani B. Medical genetic ethics Islamic view and consideration

Daru. Suppl 1; 48-55, 2006.

Medical hypotheses 273. Amoli MM, Larijani B.

Would blockage of cytokines improve the outcome of pancreatic islet transplantationMedical hypotheses. 2005 Nov.

Nutrition Journal

274. Haghighian Roudsari A, Tahbaz F, Hossein-Nezhad A, Arjmand B, Larijani B, Kimiagar SM.

Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial.

Nutr J. 29;4(1):30, 2005

BMC Neurology275. Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J

Potential risk factors for diabetic neuropathy: a case control study. BMC Neurology. 5 (1): 24, 2005

Journal of Bone Mineral Metabolism

276. Hashemipour S, Larijani B, Adibi H, Sedaghat M, Pajouhi M, Bastan-Hagh MH, Soltani A, Javadi E, Shafaei AR, Bradar-Jalili R, Hossein-Nezhad A

The Status of Biochemical Parameters in Variable Degrees of Vitamin D Deficiency.J Bone Mineral Metab. 2006;24(3):213-8.

European Journal of Cardiovascular Prevention & Rehabilitation

277. Pourebrahim R, Fakhrzadeh H, Bandarian H, Tabatabaie O, Noori M, Djalilpour F, Zahedi F, Rahimi I, Heshmat R, Djavadi E, Ghotbi S, Larijani B

Household cardiovascular screening of high risk families: A school based study.

33

Eur J Cardiovasc Prev Rehabil. 13(2):229-35, 2006.

Indian Journal of Pediatrics278. Hamidi A, Fakhrzadeh H, Moayyeri A, Heshmat R, Ebrahimpour P, Larijani B.Metabolic syndrome and leptin concentrations in obese children.Indian J Pediatr. 73(7):593-6, 2006

Cytotechnology 279. Amoli MM, Moosavizadeh R, Larijani B. Optimizing conditions for rat pancreatic islet isolation

Cytotechnology. 48 (1-3):75-8, 2006.

Schizophrenia Research280. Akhondzade S, Larijani B. Correlation between testosterone gonadotropins and prolactin and severity of negative symptoms.

Schizophrenia Research. In press, 2006.

American Journal of Transplantation 281. Zahedi F, Larijani BDeceased and living organ donation in IranAm J Transplant. 2006;6(6):1493.

Lipid in Health & Disease

282. Larijani B, Haghpanah V.Shift working and risk of lipid disorder.Lipid in Health & Disease. 2006, In press.

Bone283. Abolhassani F, Moayyeri A, Naghavi M, Soltani A, Larijani B, Shalmani HT.

Incidence and characteristics of falls leading to hip fracture in Iranian population.Bone. 2006 Feb 27.

Clinical Chimistry Acta284. Meshkani R, Taghikhani M, Larijani B, Khatami S, Khoshbin E, Adeli K.

The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.Clin Chim Acta. 2006 May 19; [Epub ahead of print]

Indian Journal of cancer285. Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi AR, Tavangar SM, Malekzadeh R, Larijani B.

Endocrine cancer in Iran: based on cancer registry systemIndian J cancer. 43(2):80-5, 2006.

Arya Atherosclerosis

34

286. Ebrahimof, Hossein Nezhad A, Larijani B, et alFruit and vegetable intake in postmenopausal women with osteopeniaArya Atherosclerosis. 1 (3):183-8, 2005

Public Health287. Moayyeri A, Soltani A, Bahrami H, Sadatsafavi M, Jalili M, Larijani B. Preferred skeletal site for osteoporosis screening in high-risk populations.

Public Health. 120(9):863-71, 2006

Journal of Clinical Densitometery288. Larijani B, Moayyeri A, Keshtkar AA, Hossein-Nezhad A, Soltani A, Bahrami A, Omrani GH, Rajabian R, Nabipour I.Peak bone mass of Iranian population: the Iranian multicenter osteoporosis study.J Clin Densitom. 9(3):367-74, 2006

Nutrition in Clinical Practice

289. Hosseini S, Aimrkalali B, Heshmat R, Larijani B, Nayebi.Nutrition status of patients during hospitalization, Tehran, Iran.Nutr Clin Pract. 21 (5): 518-21, 2006

Phytotherapy Research290. Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M.

The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial.Phytother Res. 2006 Oct 30 Epub ahead of print.

Human Reproduction 291. Zahedi F, Larijani B.

Considerations of third-party reproduction in IranHum Reprod. 2006 Nov 10; [Epub ahead of print]

Applied Immunohistochemistry and Molecular Morphology292. Haghpanah V, Shooshtarizadeh P, Heshmat R, Larijani B, Tavangar SM.

Immunohistochemical Analysis of Survivin Expression in Thyroid Follicular Adenoma and Carcinoma.Appl Immunohistochem Mol Morphol. 14(4):422-425, 2006

Seminars and Congresses1. First International Congress on Medical Ethics; 1993, Tehran, Iran

Chairman

2. First International Congress on Nursing Ethics; 1994, Tehran, IranChairman

3. 3rd International Congress on Endocrine Disorders; September 1995, Tehran, IranChairman

35

4. 4th International Congress on Endocrine Disorders; November 1996, Tehran, IranChairman

5. First Congress on Out-Patient Medicine in Iran; 1998, Tehran, IranOral Presentation:

Classification of Diagnostic and Curative Services; Strategies for quality improvement in resource management

Out Patient Medicine

6. 8th Congress of Internal Medicine; 2000, Tehran, IranBoard of Directors, Scientific Committee, Executive Committee

7. Congress of genetic disorders in special diseases; 2000, Tehran, IranBoard of Directors, Scientific Committee, Executive Committee

8. 8th Congress of Infectious Diseases; 2000, Tehran, IranScientific Committee

9. International Seminar on "Recent Advancements in Molecular Diagnosis, and Treatment of Complications of Thalassemia"; 2000, Tehran, IranScientific Committee

10. Seminar, workshop, and CME on internal medicine; March 2000, TehranExecutive Committee

11. World Congress of I.M.I; November 2000, New DelhiPanel Member

12. Annual congress of Iran Pediatricians Association: “Recent Advancements in Pediatrics”; February 2001, Tehran, IranAdvisory Committee, Scientific Committee, Executive Committee

13. "Recent Advancements in Prevention, Diagnosis, Complications, Treatment and Care of Diabetes" Symposium; February 2001, Tehran, IranAdvisory Committee, Scientific Committee

14. 9th Congress of Internal Medicine; March 2001, Tehran, IranChairman, Board of Directors, Scientific Committee

15. 12th Congress of Iranian Internists Society; May 2001, Imam's Hospital, Tehran, IranBoard of Directors, Advisory Committee, Scientific Committee

16. "New Horizons in Education and Treatment of Diabetes" Congress; May 2001, Imam's Hospital, Tehran, IranChairman, Scientific Committee

17. 3rd International Congress of "Ramadan" Fasting; October 2001, Tehran, IranAdvisory Committee, Scientific Committee

18. 6th International Congress of Endocrine Disorders; October 2001, Tehran, IranAdvisory Committee, Scientific Committee, Executive Committee

19. First national meeting of Iranian general practitioners; 2001, Tehran, IranBoard of Directors

20. 13th Congress of Iranian Internists Society; February 2002, Tehran, IranScientific Committee, Panel Member, Executive Committee

21. Seminar of Lipid Disorders and Coronary Artery Diseases; March 2002, Tehran, Iran

36

Director

22. First Congress on Prevention of Non-Communicable Diseases; 2002, Tehran, IranScientific Committee

23. First International Seminar on The Complications of Thalassemia in Adolescents; April 2002, Tehran, IranScientific Committee

24. 10th Congress of Internal Medicine; March 2002, Tehran, IranScientific Committee

25. First International Congress on Hematology, Oncology, and BMT; 2002, Tehran, IranScientific Committee

26. First Congress on "From Clinics to Laboratory in Gastroenterology"; November 2002, Tehran, IranScientific Committee

27. Health and Islam; January 2003, Tehran, IranScientific Committee, Executive Committee

28. National Congress on Burning; January 2003, TehranScientific Committee

29. Emergency Medicine Leadership Workshop; 2003, Imam's Hospital, Tehran, IranBoard of Directors, Scientific Committee

30. The 2nd International Diabetes Update Seminar; 5-6 March 2003, Tehran, IranChairman, Scientific CommitteeOral Presentation: Hot topics in diabetes mellitus

31. 14th Congress of Iranian Internists Society; May 2003, Imam's Hospital, Tehran, IranBoard of Directors, Advisory Committee, Scientific Committee

32. The second congress on prevention of non-communicable diseases; October 2003, Tehran, IranScientific CommitteeOral Presentation: Prevention of Osteoporosis

33. The Endocrinology Symposium; May 2004, Tehran, IranBoard of Directors, Scientific Committee

34. 15th Congress of Iranian Internists Society; May 2004, Imam's Hospital, Tehran, IranBoard of Directors, Advisory Committee, Scientific Committee

35. The First Seminar on Continuing Medical Education for Internists; June 2004, Tehran, IranBoard of DirectorsOral Presentation: Treatment and follow up of diabetes mellitus type 2

36. Annual congress of Iran Pediatricians Association and 24th memorial congress of Professor Mohammad Gharib; February 2004, Tehran, IranScientific Committee

37. The second world congress on Mulla Sadra and transcendent philosophy; May 2004, Tehran, IranOral Presentation: The effects of ethics philosophies on the applied decision making in medical ethics

37

38-The First International Seminar on” Prevention, Diagnosis and treatment of Osteoporosis September 2004 . Tehran Chairman of Seminar

Oral Presentation: Osteoporosis in Iran

39-International conference on Diabetes and obesity Tehran April 2005-05-22 Chairman of seminar

Oral Presentation: Burden of diabetes in Iran

40- Regional consultation on genetic diseases prevention and care Riyadh, Saudi Arabia, 21-23 Nov 2005. WHO temporary adviser.

Oral Presentation: Medical Genetic Ethics

Books1. Medical Ethics (published by the Iranian Ministry of Health and Medical Education), 19902. Complicated problems in medical Ethics, 19913. A, B, C of Diabetes Mellitus (Translation), 19914. Endocrine Diseases. (Translated from Harrison's Textbook of Internal Medicine), 19925. Metabolic diseases and Calcium Metabolism and Bone disease. (Translated from Harrison's

Textbook of Internal Medicine), 19926. Nutrition (Translated from Harrison's Textbook of Internal Medicine), 19927. Basic and Clinical Immunology (Translation), 19938. A, B, C of Hypertension (Translation), 19949. Endocrine & Metabolism, 1995

10. Syllabus of Endocrinology and Metabolism (Translation), 199411. Health and education in medicine, 199512. Health in the I.R. of Iran, 199813. Patients' rights in Europe (Translation), 199814. An over view in Organ transplantation, 199915. Diabetes and exercise, 199916. Gestational diabetes, 199917. Life with cholesterol, 199918. Diabetes and pregnancy, 200019. Abstracts of the Seminar on Internal Medicine, 200020. Medical Ethics, 200121. Abstracts of the Seminar on Osteoporosis, 200122. Abstracts of the Seminar on Gestational Diabetes Mellitus, 200123. Abstracts of the Seminar on Lipid Disorders and Coronary Disease, 200124. Abstracts of the "New Horizons in Education and Treatment of Diabetes" Seminar, 200125. Endocrine emergencies, 200126. Prevention of cardiovascular diseases, part 7: Cholesterol and lipids, 200227. Review articles about Vitamin D, 200228. Prevention of cardiovascular diseases, part 10: Smoking, 200229. Prevention of cardiovascular diseases, part 6: Obesity and overweight, 2002

38

30. Prevention of cardiovascular diseases, part 5: Diabetes, 200231. Prevention of cardiovascular diseases, part 4: Hypertension, 200232. Prevention of cardiovascular diseases, part 3: Secondary prevention, 200233. Prevention of cardiovascular diseases, part 2: Primary prevention, 200234. Prevention of cardiovascular diseases, part 1: Comprehensive plan for prevention, 200235. Ethics in Research, 200236. Dilemmas in Medical Ethics, 2003

Projects1. Comprehensive Survey of osteoporosis in Iran

2. Evaluation of Islamic fasting "Rouzeh" on biochemical indices, blood pressure, and weight of diabetic patients

3. Evaluation of exercise effect on oral hypoglycemic agents need in diabetic patients

4. Evaluation of epidermal growth factor for healing of diabetic foot ulcers

5. Evaluation of epidemiological indices of diabetic retinopathy in diabetic referred to diabetes clinic

6. Evaluation of endocrine disorders after bone marrow transplantation in Shariati hospital (1997-2001)

7. Evaluation of effect of self management education on metabolic control in diabetic patients

8. Evaluation of effect of dietary education on metabolic control in diabetic patients

9. Effects of suppressive treatment with levothyroxin on bone density

10.Effects of percutaneous ethanol injection in hot thyroid nodules

11.A prospective study about Impaired Gestational Glucose Tolerance Test in Tehran

12.Comprehensive Survey on endocrine cancers

13.Evaluation of relation between diet and BMI, and biochemical indices in diabetic patients

14.Comprehensive Survey of diabetes and pregnancy in Iran

15.Complications and effects of gestational diabetes mellitus and prevalence of overt diabetes in post GDM cases

16.Comparison of thyroidectomy outcomes in Dr. Shariati hospital with Fayyaz-bakhsh hospital

17.Comparison of Familial history in IDDM and Non - diabetic cases

18.Assessment of clinical and paraclinical profile in diabetic patients in Dr. Shariati hospital

19.Altered platelet calcium homeostasis in poorly controlled IDDM patients

20.A survey on thyroid dysfunction in adults over 60 years old

39

21.A survey on awareness about Diabetes Mellitus in Tehran

22.A Prospective study of Gestational Diabetes Mellitus prevalence in 2128 pregnant cases in Tehran

23.Diabetes Prevention and Control Survey of Tehran University of Medical Sciences

24.Risk assessment of coronary heart disease in NIDDM patients

25.The results of FNA in Dr. Shariati Hospital

26.Survey of pancreas transplantation

27.Study on prevention methods of NIDDM

28.Study on prevalence of anti thyroid-Abs in diabetic patients

29.Study on prevalence of anti gliadin-Ab in diabetic patients

30.Study of thyroid function in pre-eclampsia and eclampsia

31.Study of simplified method for screening of microalbuminuria

32.Study of neurovascular defects in NIDDM patients in Dr. Shariati hospital

33.Study of diabetes prevalence and type in relatives of IDDM patients

34.Evaluation of OCP use in diabetic women

35.Study of blood pressure in diabetic patients referred to diabetes clinic of Dr. Shariati hospital

36.Evaluation of patients with Cushing's syndrome (20 years retrospective study)

37.Review of craniopharyngioma and a retrospective study of 100 cases

38.Retrospective study of thyroid carcinoma feature in Iran over 1318 Patients referred to hospitals of Tehran University of Medical Science during last 10 years

39.Retrospective study of Pendred's Syndrome (19 Cases) in the last 20 years in hospitals of Tehran University of Medical Sciences

40.Retrospective study of patients with diabetic foot in recent 15 years

41.Retrospective study of Nelson syndrome (1985 - 1995) in Tehran University of Medical Sciences

42.Prospective study of cardiac effects of levothyroxin suppressive therapy

43.Prevention and Control of Diabetes Mellitus in Tehran University of Medical Sciences

44.Nutritional situation and its related determinations in diabetes epidemiologic survey

45.National Program for diabetes public education

46.Thyroid dysfunction in 1800 infertile women in Dr. Shariati Hospital

47.Study of dermatological manifestations in diabetic patients

40

Doctoral Theses1 Qualitative and Quantitative Assessment of Respiratory Explosion of Zn Phagocytosis

System in Diabetic Patients; Shoushtari Zadeh, Nariman, 1992

2 About of philosophy of medical ethics; Kazemi Said, 1992-1993

3 Retrospective study of 100 cases of craniopharyngioma; Kargar Shadab, 1993

4 Retrospective study of thyroid cancer in Tehran University of Medical Sciences hospital; Khajehdini, Shaikh Mozafari, 1994

5 Retrospective study of 100 patients with diabetes mellitus in Shariati hospital; Parsa, Sarvi, 1994

6 Knowledge Attitude and practice about diabetes mellitus in Tehran population; Khoshniat, 1994

7 Epidemiological study of diabetes mellitus (Type II) in Tehran population; Sadjadi, Jangodaz, Shirzad, 1994-1995

8 Clinical manifestation and paraclinical findings in women with GDM; Maleki, Abbasvandi, 1995

9 Retrospective study of diabetic foot patients admitted in Dr. Shariati & Imam Hospitals; Khani, Shajarian, 1995

10 Retrospective study of Pendred's syndrome (19 cases) in the last 20 years in Tehran University of medicine hospitals; Keigobad, 1995

11 Retrospective study of the patients with Cushing's syndrome, admitted in Dr. Shariati & Imam Hospital during last 20 years. (90 cases); Elahian, 1995

12 Study of family history in pregnant women with IGT; Navab, 1995

13 Evaluation of primary Screening test accuracy in prediction of IGT at pregnancy; Keshvarzian, 1995

14 Study of causes & some post operative medical complications of total and subtotal thyroidectomy, admitted patients in Dr. Shariati hospital (1991 - 1992); Farokhpour, 1995

15 Study of relationship between GDM and abortion & other complications; Lajevardi, 1995

16 Study of the complications and pregnancy outcome and the frequency of overt diabetes following GDM at postpartum; Alnabi Amlashi, Azarakhsh, 1995-1996

17 Study of thyroid function test at general ICU of Shariati Hospital; Saliminejad, 1995-1996

18 Thyroid dysfunction in 1800 cases referred to infertility department of Dr. Shariati hospital; Motalebi, Adibi, 1996

19 Learning sexual ethics and physician - patient relationship; Aziz Afshari. 1996-1997

20 Retrospective study of 68 cases with insulinoma admitted in Tehran & Shahid Beheshti medical university hospitals; Moosavi lar, 1996-1997

21 The study of thyroid dysfunction in geriatric group and relationship between levels of the cholesterol & triglyceride and thyroid disorders; Eghbali, Amir Alevi, 1996-1997

22 Transplantation & Brain death, Medical Ethics & Islamic Learning; Aghakhani, 1997

41

23 Retrospective study of pheochromocytoma in Tehran University of Medical Sciences. (1959-1996); Sarhadi, 1997

24 Comparison of serum zinc in NIDDM patients and healthy people via atomic absorption method; Sheikh Hassani, 1997

25 Evaluation of efficacy of serum fructosamine as an indicator for glycemic control in diabetic patients; Shafai, 1997-1998

26 Evaluation of medical ethics criteria in 51 research theses in Tehran University of Medical Sciences; Rashidian, 1998

27 Invitro purification of islet cells in rat and assessment of their secretory function & Effect of glucose & potassium on insulin secretion from islet cells isolated from rat pancreas; Mirzajani, Farzami, 1999

28 Prevalence of diabetic retinopathy and its risk factors; Kamali, Moradi, Abdolahi, 1999

29 Assessment of N-Acetyl-b-glucose aminidase in diabetic patients; Salimi, Jalali, 1999

30 Prevalence of non insulin dependent diabetes mellitus and impaired glucose tolerance test in 20-64 year old population of Boushehr in 1996; Osphouri, 1999-2000

31 Effect of boiled eucalyptus leaves on blood glucose and lipid profile of patients with diabetes type 2; Karimian, Mollaghaffari, 2000

32 Adverse effects of medications used in diabetes or thyroid disorders; Edrisian, Sharifzadeh, 2000-2001

33 Study of risk factors and effective treatments of diabetic foot ulcers; Fadii M, Afshari M, 2001

34 Study of the effect of chemotherapy on the spermogram and male sex hormones in Hodgkin’s and Non- Hodgkin’s lymphoma patients and patients candidate for BMT; Khalilian, Mirdamadi, 2001

35 Accuracy of micral test in detection of microalbuminuria compared to the standard immunoturbidometry in diabetic patients referring to the Diabetes Clinic of Dr. Shariati Hospital 2000-2002; Farsi, Shirzad, 2002

36 Clinical course and therapeutic results of hot thyroid nodules. 1987-1997; Roya Zamani, 2002

37 Assessment of efficacy of Pentoxyphilin in reduction of oxidative stress, improvement of antioxidant property and effect on nitric oxide and epidermal growth factor in type II diabetes. 2005-6; Mania Radfar.

42